Αποτελέσματα Αναζήτησης
24 Φεβ 2024 · Osteoporosis causes bones to become weak and brittle — so brittle that a fall or even mild stresses such as bending over or coughing can cause a break. Osteoporosis-related breaks most commonly occur in the hip, wrist or spine. Bone is living tissue that is constantly being broken down and replaced.
28 Αυγ 2024 · Bisphosphonates are often the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel, Atelvia), a weekly or monthly pill. Ibandronate, a monthly pill or quarterly intravenous (IV) infusion. Zoledronic acid (Reclast), an annual IV infusion.
24 Φεβ 2024 · Treatment recommendations are often based on an estimate of your risk of breaking a bone in the next 10 years using information such as the bone density test. If your risk isn't high, treatment might not include medication and might focus instead on modifying risk factors for bone loss and falls.
18 Μαρ 2022 · Symptoms of hypoalbuminemia are typically related to conditions affecting your liver, kidneys and heart, as well as nutritional deficiencies. Treatment to address the underlying condition can improve albumin protein levels. What causes hypoalbuminemia? An underlying medical condition causes hypoalbuminemia.
20 Ιουλ 2023 · Osteoporosis. Osteoporosis silently weakens your bones, which can make you more likely to experience a bone fracture (broken bone). You can prevent bone density loss with treatments and exercise. Ask your provider about a bone density test if you’re over 65 or have a family history of osteoporosis.
Both nonpharmacological therapy (calcium and vitamin D supplementation, weight-bearing exercise, and fall prevention) and pharmacological treatments (antiresorptive and anabolic agents) may be helpful in the prevention and treatment of osteoporosis.
The Clinician’s Guide offers concise recommendations regarding prevention, risk assessment, diagnosis, and treatment of osteoporosis in postmenopausal women and men aged 50 years and older. It includes indications for bone densitometry as well as fracture risk thresholds for pharmacologic intervention.
